Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-15

Clinical Trial Update: SIMBRINZA® Suspension BID as an Adjunctive to Prostaglandin Analogue (PGA) [Phase 4]

View source ↗

Summary

Phase 4 trial updating SIMBRINZA suspension as adjunctive therapy to prostaglandin analogues in open-angle glaucoma or ocular hypertension; study completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Simbrinza (brinzolamide/brimonidine)

Snippet

Sponsor: Alcon Research | Conditions: Open-Angle Glaucoma, Ocular Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2018-11-15